Ascentage Pharma Group International Adr (AAPG)

03:18 AM

Cash per share of Ascentage Pharma Group International Unsponsored ADR – LS:A40ZYR - TradingView

03:18 AM

Dec 04, 2025

Ascentage Pharma Announces Global Registrational Phase III Study of Olverembatinib in First-Line Treatment of Ph+ ALL Cleared by US FDA and EMA - GlobeNewswire Inc.

Dec 04, 2025

Dec 04, 2025

ETFs Investing in Ascentage Pharma Group International Unsponsored ADR Stocks - TradingView

Dec 04, 2025

Dec 01, 2025

Ascentage Pharma to Highlight Key Data from ASH 2025 in Upcoming Webcast - TipRanks

Dec 01, 2025

Nov 28, 2025

Ascentage Pharma Announces New RSU and Share Option Grants - TipRanks

Nov 28, 2025

Nov 26, 2025

Analysts’ Top Healthcare Picks: Amgen (AMGN), Opus Genetics (IRD) - The Globe and Mail

Nov 26, 2025

Nov 25, 2025

Ascentage Pharma’s Olverembatinib Shows Promise in Rare GIST Treatment - TipRanks

Nov 25, 2025

Nov 25, 2025

Ascentage Pharma Group International (NASDAQ:AAPG) Now Covered by Analysts at Truist Financial - Defense World

Nov 25, 2025

Nov 22, 2025

Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap DownHere's What Happened - MarketBeat

Nov 22, 2025

Nov 20, 2025

Ascentage Pharma Group International ADR (AAPG) Stock Price Prediction for 2026, 2030-2040 - Traders Union

Nov 20, 2025

Nov 20, 2025

Ascentage Pharma Group International ADR (AAPG) Stock Price Today | Live Chart & News - Traders Union

Nov 20, 2025

Nov 20, 2025

Ascentage Pharma Group International ADR (AAPG) Stock Price Prediction: Today, Tomorrow, Next Week - Traders Union

Nov 20, 2025

Nov 19, 2025

Ascentage Pharma Group International (NASDAQ:AAPG) Stock Price Down 12.2%Should You Sell? - MarketBeat

Nov 19, 2025

Nov 19, 2025

Ascentage Pharma to Engage Investors at December 2025 Conferences - TipRanks

Nov 19, 2025

Nov 11, 2025

Analysts Offer Insights on Healthcare Companies: Allogene Therapeutics (ALLO), NeurAxis, Inc. (NRXS) and Celcuity (CELC) - The Globe and Mail

Nov 11, 2025

Nov 11, 2025

Analysts Have Conflicting Sentiments on These Healthcare Companies: AMN Healthcare Services (AMN) and Crispr Therapeutics AG (CRSP) - The Globe and Mail

Nov 11, 2025

Nov 05, 2025

Promising Potential of Ascentage Pharma’s Key Assets: Olverembatinib and Lisaftoclax Drive Buy Rating Amidst Risks - TipRanks

Nov 05, 2025

Nov 04, 2025

Free cash flow per share of Ascentage Pharma Group International Unsponsored ADR – SWB:36X0 - TradingView

Nov 04, 2025

Oct 30, 2025

Ascentage Pharma to Engage Investors at November Conferences - TipRanks

Oct 30, 2025

Oct 30, 2025

Centurion Acquisition Corp. (NASDAQ:ALFUW) Short Interest Down 57.1% in October - Defense World

Oct 30, 2025

Oct 29, 2025

Ascentage Pharma Group InternationalUnsponsored ADR (NASDAQ:AAPG) Short Interest Down 82.7% in October - MarketBeat

Oct 29, 2025

Oct 27, 2025

Zymeworks’ Promising FRa ADC Potential: Buy Rating Affirmed by Analyst - TipRanks

Oct 27, 2025

Oct 21, 2025

Revolution Medicines: Strong Buy Rating Driven by Innovative Oncology Advancements and Strategic Market Position - TipRanks

Oct 21, 2025

Oct 20, 2025

Promising Early-Stage Data and Competitive Positioning Support Buy Rating for Zymeworks’ ADC Platform - TipRanks

Oct 20, 2025

Oct 15, 2025

Allogene Therapeutics (ALLO) was downgraded to a Sell Rating at J.P. Morgan - The Globe and Mail

Oct 15, 2025

Oct 10, 2025

Ascentage Pharma Group International (NASDAQ:AAPG) Trading Up 3.5%Here's What Happened - MarketBeat

Oct 10, 2025

Oct 09, 2025

J.P. Morgan Reaffirms Their Buy Rating on Roivant Sciences (ROIV) - The Globe and Mail

Oct 09, 2025

Oct 07, 2025

Ascentage Pharma Engages Investors at October 2025 Conferences - TipRanks

Oct 07, 2025

Oct 06, 2025

Ascentage Pharma Group International (OTCMKTS:ASPHF) Short Interest Up 70.0% in September - Defense World

Oct 06, 2025

Oct 03, 2025

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

Oct 03, 2025

Sep 20, 2025

Ascentage Pharma Group International (NASDAQ:AAPG) Stock Price Down 4.5%Here's What Happened - MarketBeat

Sep 20, 2025

Sep 03, 2025

Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap UpStill a Buy? - MarketBeat

Sep 03, 2025

Sep 01, 2025

Here's Why Ascentage Pharma Group InternationalUnsponsored ADR (AAPG) Is a Great 'Buy the Bottom' Stock Now - Yahoo Finance

Sep 01, 2025

Aug 28, 2025

Ascentage Pharma to Engage with Investors at September Conferences - TipRanks

Aug 28, 2025

Aug 17, 2025

Ascentage Pharma Group International (NASDAQ:AAPG) Reaches New 52-Week High – Should You Buy? - Defense World

Aug 17, 2025

Aug 08, 2025

Ascentage Pharma to Announce 2025 Interim Results and Corporate Update - The Globe and Mail

Aug 08, 2025

Aug 01, 2025

Ascentage Pharma to Engage in Evercore China Biotech Summit - TipRanks

Aug 01, 2025

Jul 17, 2025

Ascentage Pharma Completes Offshore Placement to Boost Global Operations - TipRanks

Jul 17, 2025

Jul 16, 2025

Ascentage Pharma Group International – Unsponsored ADR’s (NASDAQ:AAPG) Lock-Up Period Set To End on July 23rd - Defense World

Jul 16, 2025